Investing.com - Centogene reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Centogene announced earnings per share of €-0.353 on revenue of €11.71M. Analysts polled by Investing.com anticipated EPS of €-0.382 on revenue of €12.84M.
Centogene shares are down 28.95% from the beginning of the year, still down 89.18% from its 52 week high of €11.09 set on September 30, 2021.
Centogene follows other major Healthcare sector earnings this month
Centogene's report follows an earnings beat by Merck ADR on September 9, who reported EPS of €0.5392 on revenue of €5.69B, compared to forecasts EPS of €0.5165 on revenue of €5.57B.
Veeva Systems A had beat expectations on August 31 with second quarter EPS of €1.03 on revenue of €534.22M, compared to forecast for EPS of €1.01 on revenue of €530.71M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar